+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars And Biosuperiors Market Research Reports

From
Biosimilars Market 2025-2029 - Product Thumbnail Image

Biosimilars Market 2025-2029

  • Report
  • February 2025
  • 219 Pages
  • Global
From
From
From
Biosimilars Training Course (September 30, 2025 October 1, 2025) - Product Thumbnail Image

Biosimilars Training Course (September 30, 2025 October 1, 2025)

  • Conference
  • October 2025
  • 2 Days
  • Global
Biosimilars Market - Products, Applications and Regulations - Product Thumbnail Image

Biosimilars Market - Products, Applications and Regulations

  • Report
  • February 2025
  • 227 Pages
  • Global
From
US Biosimilar Market: Insights & Forecast (2024-2028) - Product Thumbnail Image

US Biosimilar Market: Insights & Forecast (2024-2028)

  • Report
  • August 2024
  • 72 Pages
  • United States
From
Europe Biosimilar Market Report 2025-2033 - Product Thumbnail Image

Europe Biosimilar Market Report 2025-2033

  • Report
  • January 2025
  • 126 Pages
  • Europe
From
From
Biosimilar Monoclonal Antibodies Market Report 2022-2032 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Market Report 2022-2032

  • Report
  • July 2022
  • 461 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Biosimilars and Biosuperiors market is a rapidly growing sector of the pharmaceutical industry. Biosimilars are biologic drugs that are highly similar to an existing biologic drug, while biosuperiors are biologic drugs that are more effective than an existing biologic drug. Biosimilars and biosuperiors are used to treat a variety of conditions, including cancer, autoimmune diseases, and inflammatory diseases. Biosimilars and biosuperiors are developed using advanced biotechnology techniques, such as recombinant DNA technology and monoclonal antibody technology. These drugs are designed to be more cost-effective than their original counterparts, while still providing the same therapeutic benefits. The Biosimilars and Biosuperiors market is expected to continue to grow in the coming years, as more biologic drugs are developed and approved for use. Companies in this market include Amgen, Pfizer, Merck, and Novartis. Show Less Read more